Management changes in Qlife Holding AB

Qlife Holding AB is pleased to announce the appointment of Peter Thorsen as the new Chief Financial Officer (CFO) of the company, effective January 1st, 2024. Mr. Thorsen will succeed Kasper Boel Rousøe, bringing with him a wealth of financial expertise and leadership experience.

Peter Thorsen is a Certified Public Accountant (CPA) with an impressive background in finance, having previously served in key roles at prominent organizations such as EY, DSV A/S, Domea, Widex A/S, and TeliaSonera. His extensive experience in finance leadership positions, combined with his strategic vision and analytical skills, make him a valuable addition to the Qlife team.

“We are delighted to welcome Peter Thorsen as our new CFO,” says Thomas Warthoe, Chief Executive Officer of Qlife. “His proven track record and deep understanding of financial management will play a crucial role in supporting Qlife’s growth and strategic initiatives. We are confident that Peter’s expertise will contribute significantly to our future success.”

Peter Thorsen expressed his enthusiasm for joining Qlife Holding AB, stating, “I am honored to be part of a company that is at the forefront of innovation in the healthcare industry. Qlife’s commitment to advancing digital health solutions aligns with my own professional values, and I am eager to contribute to the company’s financial success.”

As the incoming CFO, Peter Thorsen will oversee the financial strategy, planning, and reporting functions at Qlife Holding AB. His appointment reflects the company’s commitment to maintaining strong financial governance and fostering sustainable growth.

For more information please contact:

Thomas Warthoe, CEO
tw@egoo.health
+45 21 63 35 34

Qlife is a medical device company born to challenge the status quo in healthcare. We work to shift the perspective and turn today’s view on healthcare into tomorrow’s focus on health- empowerment. We are on a quest to empower people with more accessible ways to understand their health – so that they can move beyond reactive care towards proactive wellbeing. It’s how we contribute to improving quality of life for every individual and for the greater society.

Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor.
Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.